IQGAP1 Is a Novel CXCR2-Interacting Protein and Essential Component of the “Chemosynapse” by Neel, Nicole F. et al.
IQGAP1 Is a Novel CXCR2-Interacting Protein and
Essential Component of the ‘‘Chemosynapse’’
Nicole F. Neel
1,2., Jiqing Sai
1,2., Amy-Joan L. Ham
3, Tammy Sobolik-Delmaire
1,2, Raymond L.
Mernaugh
3, Ann Richmond
1,2*
1Department of Veterans Affairs, Nashville, Tennessee, United States of America, 2Department of Cancer Biology, Vanderbilt University School of Medicine, Nashville,
Tennessee, United States of America, 3Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America
Abstract
Background: Chemotaxis is essential for a number of physiological processes including leukocyte recruitment. Chemokines
initiate intracellular signaling pathways necessary for chemotaxis through binding seven transmembrane G protein-couple
receptors. Little is known about the proteins that interact with the intracellular domains of chemokine receptors to initiate
cellular signaling upon ligand binding. CXCR2 is a major chemokine receptor expressed on several cell types, including
endothelial cells and neutrophils. We hypothesize that multiple proteins interact with the intracellular domains of CXCR2
upon ligand stimulation and these interactions comprise a ‘‘chemosynapse’’, and play important roles in transducing CXCR2
mediated signaling processes.
Methodology/Principal Findings: In an effort to define the complex of proteins that assemble upon CXCR2 activation to
relay signals from activated chemokine receptors, a proteomics approach was employed to identify proteins that co-
associate with CXCR2 with or without ligand stimulation. The components of the CXCR2 ‘‘chemosynapse’’ are involved in
processes ranging from intracellular trafficking to cytoskeletal modification. IQ motif containing GTPase activating protein 1
(IQGAP1) was among the novel proteins identified to interact directly with CXCR2. Herein, we demonstrate that CXCR2 co-
localizes with IQGAP1 at the leading edge of polarized human neutrophils and CXCR2 expressing differentiated HL-60 cells.
Moreover, amino acids 1-160 of IQGAP1 directly interact with the carboxyl-terminal domain of CXCR2 and stimulation with
CXCL8 enhances IQGAP1 association with Cdc42.
Conclusions: Our studies indicate that IQGAP1 is a novel essential component of the CXCR2 ‘‘chemosynapse’’.
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Introduction
Chemokine receptors activate many intracellular signaling path-
ways through their coupling to G proteins. However, recent evidence
suggests the importanceof G protein-independent signaling pathways
in the chemotactic response. The specific adaptor molecules that link
activated chemokine receptors to these alternative signaling pathways
are largely unknown. One might hypothesize that there is a dynamic
exchange of proteins associated with the cytoplasmic domain of
activated chemokine receptors that comprise a ‘‘chemosynapse’’ that
serves a hub for signaling required for the chemotactic response.
These interacting proteins effectively initiate organization of the actin
cytoskeleton, receptor internalization and subsequent trafficking, and
initiation of signaling needed for chemotaxis and other chemokine
mediated cellular responses. The importance of chemokine receptors
in a number of pathological conditions such as inflammation,
angiogenesis, and cancer make them ideal for therapeutic targeting.
Proteomic screening for the identification of novel interacting
proteins is an ideal technique because it allows components of large
signaling complexes within the cell to be elucidated. The technology
not only allows identification of the proteins but the conditions under
which these proteins interact under physiological conditions.
I nt h ec u r r e n ts t u d y ,w ed e s c r i b ean o v e lp r o t e o m i c st e c h n i -
que which led to the identification of a novel CXCR2/IQGAP1
interaction. This approach has a number of benefits. First, proteins
that bind CXCR2 indirectly can be identified using this method.
Second, conformation-specific and modification-specific interactions
can be identified. Third, interactions mediated through other
intracellular domains of the receptor in addition to the carboxyl-
terminus can be identified. Finally, immunoprecipitation of CXCR2-
associating proteins in cells stimulated with ligand allows identifica-
tion of dynamicand transient interactions. Use of this approach led to
PLoS ONE | www.plosone.org 1 August 2011 | Volume 6 | Issue 8 | e23813the identification of several novel CXCR2-interacting proteins that
may be involved in the intracellular trafficking of the receptor,
initiation of the chemotactic response, and activation of signaling
pathways.
IQGAP1 was identified as a novel CXCR2-interacting protein.
We propose that this interaction is an essential component of the
dynamic ‘‘chemosynapse’’. IQGAP1 is a major scaffolding protein
involved in cytoskeletal organization and signaling through
regulation of a number of cellular functions including adhesion,
migration,and integrationofcomplexsignalingpathwayswithinthe
cell. IQGAP1 is a 188 kDa protein that contains multiple domains
(calponin-like actin binding domain, a WW domain that binds
proline-rich motifs of multiple proteins, an IQ calmodulin-binding
region, and a RasGAP domain) and localizes to the leading edge in
migrating cells where it cross-links actin filaments [1,2]. Interest-
ingly, IQGAP1 contains a RasGAP homology domain but does not
stimulate the GTPase activity. In fact, it inhibits the intrinsic
GTPase activity of Rac1 and Cdc42, stabilizing them in their active
forms [3,4]. As expected, IQGAP1 has a fundamental role in cell
motility. Expression of dominant negative IQGAP1, a form that is
unable to bind Rac1 and Cdc42, or siRNA directed against
IQGAP1 severely impairs cell motilifty and invasion [5]. Specifi-
cally, it plays an essential role in polarization of a migrating cell
through its interactions with Rac1/Cdc42, APC, CLIP-170, actin
and calmodulin (reviewed in [6]). Not only does IQGAP1 play a
fundamental role in cell migration, it also serves as a scaffold for the
MAP kinase signaling cascade [7,8], suggesting that it may also play
an important role in cell proliferation.
Materials and Methods
Cell culture
We have used HEK-293 and HL-60 cells in the experiments
described herein. For all described experiments HL-60 cells were
differentiated along the neutrophilic lineage as described previ-
ously [9]. Briefly, HL-60 cells were cultured in RPMI 1640
medium supplemented with 25 mM HEPES (pH 7.4), 10% fetal
bovine serum (Atlanta Biologicals, Atlanta, GA), L-glutamine, 100
units/ml pen/strep (Mediatech, Inc., Herndon, VA). Cells were
subcultured every 3–4 days to a cell density of 1610
6 cells/ml. To
differentiate HL60 cells along the granulocytic lineage, cells were
inoculated at a density of 2610
5 cells/ml in antibiotic-free
medium containing 1.3% Dimethyl sulfoxide (DMSO) (endotox-
in-free, Sigma) and cultured for 6–7 days. HEK293 cells were
maintained in Dulbecco’s Modified Eagle’s Media with 10% fetal
bovine serum and changed to serum free medium prior to assay.
Purification of human neutrophils
Human blood from healthy donors was mixed with equal
volumes of 3% dextran solution and set for sedimentation for
20 min at room temperature. The primary neutrophils were
purified in a Ficoll-Hypaque gradient by centrifugation at 4006g
for 40 min at room temperature.
Immunoprecipitation of CXCR2 protein complexes
Normal rabbit IgG antibodies (Jackson Immunoresearch, West
Grove, PA) and rabbit polyclonal anti-CXCR2 antibodies were
coupled to NHS-activated Sepharose 4 Fast Flow matrix (GE
Healthcare, Piscataway, NJ) at a 4:1 ratio (mg antibody: ml
matrix). Anti-CXCR2 affinity purified polyclonal antibody was
generated in our laboratory and described previously [10].
Coupled antibody beads were blocked with ethanolamine (Sigma,
St. Louis, MO) to minimize non-specific binding of proteins to
matrix. For immunoprecipitations, HL-60 cells stably expressing
CXCR2 were differentiated for 7 days in 1.3% DMSO and
stimulated with vehicle (0.1% BSA/PBS) or 100 ng/ml CXCL8
for 1 min. Cells were resuspended in lysis buffer (50 mM Tris-
HCl, pH 7.5, 0.05% Triton X-100, 300 mM NaCl), cleared by
centrifugation, and pre-cleared with normal rabbit IgG-coupled
beads. Precleared lysates were then incubated with normal rabbit
IgG-coupled beads (Mock) or anti-CXCR2 rabbit antibody-
coupled beads and associating proteins were eluted with 2X
Laemmli sample buffer, heated for 65uC for 10 mins, loaded
directly onto a 10% polyacrylamide gel with no stacker gel. The
electrophoresis was continued until the dye front ran approxi-
mately 1 cm into the gel and proteins were stained with colloidal
blue stain (Invitrogen, Carlsbad, CA). Excised gel bands were
subjected to in-gel trypsin digest [11] and tryptic peptides
submitted for LC/MS/MS analysis. Reverse co-immunoprecita-
tion assays were performed in the same way with modifications as
follows: Differentiated HL60 cells were cross-linked with 2 mM
DSP (Cat# 22585, Pierce Biotechnology, Rockford, IL) immedi-
ately after stimulation with 100 ng/ml CXCL8. Then cells were
lysed in 1x RIPA buffer supplemented with proteinase inhibitor
cocktail (Sigma, St. Louis, MO) and phosphatase inhibitor cocktail
2 and 3 (Sigma, St. Louis, MO). Cell lysates were pre-cleared with
normal rabbit IgG and protein A/G agarose beads (Santa Cruz
Biotech, CA) and then precipitated with anti-IQGAP1 polyclonal
rabbit antibody (Santa Cruz Biotech, CA) and protein A/G
agarose beads.
LC/MS/MS analysis and protein identification
One dimensional LC/MS/MS analysis was performed as
described previously [12]. Briefly, analysis was performed using
a Thermo Finnigan LTQ ion trap mass spectrometer and peptides
were separated on a packed capillary tip (100 mm 611 cm) with
C18 resin (Monitor C18, 5 mm, 100 A ˚, Column Engineering, ON,
Canada). MS/MS spectra of peptides was performed using data-
dependent scanning in which one full MS spectrum, using a full
mass range of 400-200 amu, was followed by 3 MS-MS spectra.
Protein matches were searched with the Sequest algorithm
(TurboSEQUEST v.27 (rev. 12) on a high speed, multiprocessor
Linux cluster in the Vanderbilt Advanced Computing Center for
Research) and preliminarily filtered using the criteria described
previously [12]. Once the peptides were filtered based on these
criteria, all matches that had less than two peptide matches were
eliminated. These filtering criteria routinely achieved a false
discovery rate of ,1% in similar datasets. Protein matches were
also validated by filtering the data through Protein Prophet in the
Trans Proteomic Pipeline (Version: 4.0) (TPP v2.7 MIST rev.2,
Build 200601131056).
Immunofluorescence staining and confocal microscopy
Cells in serum-free RPMI were seeded on glass coverslips
coated with 100 mg/ml human fibronectin (BD Biosciences, San
Diego, CA) and stimulated globally with vehicle (0.1% BSA/PBS)
or 100 ng/ml CXCL8 diluted in 0.1% BSA/PBS at 37uC for
indicated times. Cells were fixed in 4% paraformaldehyde for
10 min, permeabilized in 0.2% Triton X-100/PBS for 5 min,
blocked in 10% normal donkey serum for 30 min (Jackson
Immunoresearch Laboratories, Inc., West Grove, PA). Anti-
CXCR2 rabbit polyclonal (Mueller et al, 1994) and anti-IQGAP1
mouse monoclonal (Invitrogen, Carlsbad, CA) primary antibodies
were added and incubated for 2 h at room temperature. After
washing three times with 0.1% Tween 20/PBS, the coverslips
were incubated with fluorescence-conjugated secondary antibod-
ies for 1 h. After final three washes with 0.1% Tween 20/PBS,
coverslips were mounted with ProLong Gold antifade reagent
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a LSM-510 Meta laser scanning microscope (Carl Zeiss, Thorn-
wood, NY) with a 40X 1.3 numerical aperture oil immersion lens
and images were processed by Photoshop software (Adobe
Systems). Colocalization of CXCR2 with IQGAP1 was quantified
using Metamorph Imaging System software package (Molecular
Devices Corporation, Sunnyvale, CA). Threshold levels for all
images were kept consistent among all images. Images were taken
from six fields of view per time point in two separate experiments.
The percent co-localization is indicative of the area of CXCR2
and stained fluorescent pixels overlapping that of IQGAP1.
Construction of GST-IQGAP1 plasmids and preparation of
recombinant GST-IQGAP1 protein from Escherichia coli
The pGEX-2T-IQGAP1-amino-terminus (NT) (aa 1-863) and –
carboxyl-terminus (CT) (aa 864-1657) was a generous gift from Dr.
David Sacks and were described previously [3]. To prepare the
cDNA for GST-IQGAP1 1-160 and GST-IQGAP1 1-265 PCR
was performed on pGEX-2T-IQGAP1-NT using the forward
primers containing a 59 BamHI site and a 39 XhoI site. The same
forward primer was used to prepare both fragments. The following
primers were used for 1-160 amplification: forward-59 ctctagg-
gatccatgtccgccgcagacgaggtt 39 and reverse- 59 ctagctctcgagttagaa-
caggtacaaactgac 39. The following reverse primer was used for 1-
265 amplification: 59ctagctctcgagttaagcctggtaaagtatat cctgg 39.
Fragments were amplified and digested with BamHI and XhoI,
purified, and ligated into the pGEX-6P1 vector. All plasmids were
purified using Sigma DNA maxiprep kits (Sigma, St. Louis, MO)
according to the manufacturer’s instructions. GST-fusion proteins
were prepared from Escherichia coli as described previously. Briefly,
cultures were inoculated and grown until OD600 =0.6-0.8 and
expression was induced with 10 mM isopropyl b-D-1-thiogalacto-
pyranoside (IPTG) (Sigma, St. Louis, MO) 4 hs at 30uC. Bacteria
were harvested, proteins extracted by sonication, and isolated by
incubation with glutathione-agarose (Sigma, St. Louis, MO).
Direct binding of purified IQGAP1-NT and GST-CXCR2
carboxyl-terminus
The GST tag was cleaved from purified GST-IQGAP1-NT
coupled to glutathione-agarose by incubating with thrombin (10
units/1 mg total protein) (GE Healthcare, Piscataway, NJ) for
16 h at 25uC. Cleaved protein was incubated with Benzamidine
Sepharose 4 Fast Flow Matrix (GE Healthcare, Piscataway, NJ) to
remove thrombin. Constructs for glutathione S-transferase (GST)
fusion proteins of the C-terminal residues of CXCR2 were
generated previously [13]. Glutathione agarose beads coupled to
GST or GST-CXCR2 carboxyl-terminus and reaction tubes were
blocked with 1% BSA for 1 h at 25uC prior to binding assay.
50 mg total GST-fusion proteins on beads were incubated with
10 mg purified IQGAP1-NT for 1 h at 4uC in binding buffer
(50 mM Tris-HCl, pH 7.5, 300 mM NaCl, 0.01% Triton X-100).
Beads were washed four times with binding buffer. Bound proteins
were eluted with 2X Laemmli sample buffer and subjected to
SDS-PAGE and western blot analysis using an anti-IQGAP1
rabbit polyclonal antibody directed against the amino-terminus of
the protein (Santa Cruz Biotechnology, Inc., Santa Cruz, CA).
Chemotaxis Assay (Boyden chamber)
Chemotaxis assays were performed as previously described
[13]. Briefly, HEK293 cells were trypsinized, washed and
resuspended in serum containing medium. Cells were maintained
at 37uC, 5% CO2 with rotation for 2 h and then cells were
washed with 0.1% BSA/serum-free medium and re-suspended in
the same medium. A 10-mm pore of polybrene filter was pre-
coated with 2 mg/ml collagen IV (Sigma) and the Boyden
chamber was assembled as described in manufacturer’s protocol.
The lower wells were filled with different concentrations of
CXCL8 (0–25 nM) or EGF (0–50 nM) and upper wells were
loaded with 10
5 cells in 200 ml. Cells were allowed to migrate in
the assembled chamber for 4-5 h at 37uC, 5% CO2. Cells on the
filter were fixed and stained with crystal violet, viewed and
counted under a 20x microscope objective. Assays were repeated
a minimum of 3 times with duplicate wells at each concentration
and 5 fields were counted per well.
Induction of Cell Polarization in a Zigmond Chamber
Purified cells (human primary neutrophils or differentiated
HL60 cells) were seeded on a coverslip pre-coated with 10 mg/ml
human fibronectin. The Zigmond chamber was assembled
according to the manufacture’s suggestions. The CXCL8 gradient
was generated between the serum-free RPMI1640 medium and
medium containing CXCL8 (25 ng/ml). Cells on the coverslips
were induced to polarize under the CXCL8 gradient for 20 min at
37uC and then immediately fixed in 4% paraformaldehyde for
10 min at room temperature. Cells were washed three times with
PBS and stored in this buffer at 4uC until use.
Results
Development of a proteomics approach to identify novel
CXCR2-interacting proteins
In order to identify proteins that differentially associate with the
un-stimulated receptor versus the activated receptor it was
important to immunoprecipitate receptor-protein complexes from
a physiologically relevant cell type. The analysis was conducted in
the HL-60 cell line differentiated into the human neutrophil
lineage because CXCR2 is essential for the inflammatory response
due to its involvement in neutrophil recruitment. Differentiated
HL-60 cells naturally express low levels of CXCR2. In order to
maximize co-immunoprecipitating proteins, however, CXCR2
was stably over-expressed in the cell lines used in these ex-
periments. An additional obstacle of performing these analyses is
the presence of high amounts of IgG from immunoprecipitation
which makes it difficult to detect spectra of peptides from less
abundant proteins. In order to address this problem, normal rabbit
IgG and anti-CXCR2 rabbit antibodies were covalently coupled
to Sepharose beads. This allowed protein complexes to be eluted
from the beads without IgG contamination.
Cells were stimulated with either vehicle or 100 ng/ml CXCL8
for 1 min and lysed in a mild buffer in order to maintain weak
interactions within protein complexes. Normal rabbit IgG- (mock
control) and anti-CXCR2-coupled beads were then used to
immunoprecipitate complexes from lysates and eluted using
Laemmli sample buffer. Eluted proteins were then loaded directly
onto a polyacrylamide resolving gel and allowed to run into the gel
approximately 1 cm. Protein bands were stained with colloidal
blue stain and excised from the gel. Tryptic peptides were
generated by in-gel trypsin digest and subjected to LC/MS/MS
analysis. Proteins were identified using the cluster version of the
SEQUEST algorithm [14] using the human subset of the
Uniref100 database (www.uniprot.org). Detailed methodology is
described in the Materials and Methods section above. Unique
proteins in each group were identified using an in-house
Vanderbilt database program called CHIPS (Complete Hierar-
chical Integration of Protein Searches). This allowed non-specific
identifications from the mock control immunoprecipitations to be
subtracted from the two experimental groups. A schematic of the
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shown in Figure 1. Some of the consistently identified CXCR2-
associating proteins identified by this method with the corre-
sponding number of peptides and frequency are listed in Table 1
and the interacting proteins identified from untreated vs. CXCL8-
stimulated cells are listed in Table 2.
IQGAP1 is a novel CXCR2 interacting protein
The signaling scaffolding protein IQGAP1 was consistently
identified with both the un-stimulated and activated receptor
immunoprecipitations using this approach. A total of six peptide
spectra were identified for IQGAP1 and spectra were identified in
three out of the four replicate experiments (Table 1). The
interaction of IQGAP1 with CXCR2 was verified by immuno-
precipation followed by western blot analysis (Figure 2A and 2B).
In support of the proteomics analyses, western blot analysis shows
an apparently equal amount of immunoreactive IQGAP1 co-IPs
with CXCR2 in untreated cells and cells stimulated with CXCL8
for 1 min. Interestingly, IQGAP1 no longer co-IPs with CXCR2
following 5 mins of CXCL8 stimulation (Figure 2A). A reverse co-
immunnoprecipitation with anti-IQGAP1 antibody followed by
Western blot for CXCR2 was performed. This assay confirmed
the association of IQGAP1 and CXCR2 (Figure 2B). Intracellular
localization of IQGAP1 was also examined upon CXCL8
stimulation by immunofluorescence staining and confocal micros-
copy. In unstimulated cells, IQGAP1 is localized just below the
plasma membrane and accumulates in membrane ruffles with
CXCR2 upon 1 min of CXCL8 stimulation (Figure 2C).
Consistent with the immunoprecipitation experiments, confocal
analyses demonstrate that upon global ligand stimulation with IL-
8, IQGAP1 localizes to membrane where CXCR2 is also localized
over a time course of 30 minutes (Figure 2C and 2D). In confocal
microscopy experiments analyzing the co-localization of IQGAP1
and CXCR2 in polarized normal human neutrophils responding
to a gradient of IL-8 chemokine in Zigmond chamber assays,
immunofluorescence staining indicated that about 60% of the
IQGAP1 was observed to be overlapping with CXCR2 in
confocal microscopy. Most of this overlap was concentrated on
the leading edge of the cells polarized toward the direction of a
CXCL8 gradient (Figure 2E and 2F). Of note, while there is a
dimunition of co-immunoprecipitating IQGAP1 and CXCR2 by
5 minutes after ligand stimulation, in confocal microscopy
experiments, these two proteins continue to co-localize at the
membrane, suggesting that though they may no longer physically
associate, they remain in the same proximity at the membrane at
the 5 minute time point.
CXCR2 interacts with the amino-terminus of IQGAP1
specifically through amino acids 1-160
To determine the domain of IQGAP1 that interacts with
CXCR2, GST-IQGAP1-amino-terminus (NT) (residues 1–863)
and –carboxyl-terminus (CT) (residues 864–1657) fusion proteins
were produced (Figure 3A). Pull-down reactions were performed
using these proteins and lysates from differentiated HL-60 cells
Figure 1. Schematic of representation of proteomics approach used to identify novel CXCR2-interacting proteins.
doi:10.1371/journal.pone.0023813.g001
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terminus of IQGAP1 interacts with CXCR2 from HL-60 cells.
GST fusion proteins of successively smaller domains within the
amino-terminus of IQGAP1 were generated to further define the
interaction domain. Amino acids 1–265 and 1–160 were both able
to efficiently interact with CXCR2 from HL-60 cells (Figure 3C).
GST fusion proteins containing residues 1-44 and 160–431 were
also generated and used in pull-down reactions. These two fusion
proteins failed to interact with CXCR2 (Supplemental Data Figure
S4). These data suggest that a region of IQGAP1 located between
residues 44 and 160 is likely the CXCR2-interaction domain.
CXCR2 directly interacts with the amino-terminus of
IQGAP1
We next sought to determine whether the IQGAP1 interaction
with CXCR2 is direct or occurs through an intermediate adaptor
protein. To investigate this, recombinant IQGAP1-amino-termi-
nus (NT) and GST-CXCR2-carboxyl-terminus were purified.
These proteins were then used in direct binding assays in order to
assess whether the two proteins can interact in the absence of other
cellular proteins. There is only a slight association of IQGAP1
with GST alone, which is not unexpected based upon the poten-
tial for some non-specific binding to GST alone. These assays
demonstrated that purified IQGAP1-NT and GST-CXCR2
carboxyl-terminus are able to bind in vitro (Figure 4). These data
suggest that CXCR2 directly interacts with the amino-terminus
of IQGAP1.
Interaction of IQGAP1 with Cdc42 is enhanced by CXCL8
stimulation
A number of studies have demonstrated that the interaction of
IQGAP1 with the small GTPases Rac and Cdc42 is affected by
various different stimuli such as cell-cell adhesion [4,15,16], cell-
matrix adhesion [16], and Ca
2+ signaling [17]. Cdc42 binds
IQGAP1 only in its GTP bound state [18]. Because Cdc42 is
activated upon CXCR2 stimulation, we sought to investigate
whether the association of Cdc42 with IQGAP1 was altered upon
CXCL8 stimulation. We examined if the association of IQGAP1
with Cdc42 was altered upon CXCL8 stimulation. To investigate
this, we immunoprecipitated IQGAP1 from differentiated HL-60
cells expressing CXCR2 stimulated with CXCL8 and examined
association of Cdc42 by western blot analysis. These experiments
demonstrated that co-immunoprecipitation of Cdc42 with IQ-
GAP1 is slightly enhanced with CXCL8 stimulation (Figure 5A).
This experiment was repeated three times with similar results
demonstrating an average of a 1.3660.1 fold increase in co-
immunoprecipitated Cdc42 following 1 min of CXCL8 stimula-
tion as quantitiated by densitometry (Figure 5B). This establishes a
potential functional link between CXCR2 activation and modu-
lation of IQGAP1 activities within the cell.
Expression of IQGAP1 1-160 (CXCR2-interacting domain)
impairs CXCR2-mediated chemotaxis
To determine whether the IQGAP 1-160 domain (CXCR2
interaction domain) will compete for CXCR2 and reduce the
endogenous interaction between CXCR2 and IQGAP1 we
transfected HEK293 cells stably expressing CXCR2 with an
expression construct encoding IQGAP1 1-160. After verifying
expression of the 1-160 domain, we compared CXCR2-mediated
chemotaxis of the cells expressing or not expressing the 1-160
domain using a modified Boyden chamber assay. Expression of
this fragment significantly inhibited CXCR2-mediated chemotaxis
of HEK293 cells as compared to cells transfected with empty
vector (Figure 6). To determine whether the inhibition was specific
for the CXCR2 mediated chemotaxis, we also examined EGF
mediated chemotaxis in the same cells. Expression of the IQGAP1
1-160 fragment in HEK-293 cells expressing CXCR2 also resulted
in significant inhibition of EGF-mediated chemotaxis in a Boyden
Table 1. Associating CXCR2 proteins identified with
proteomics.
Protein identified
Total number
of peptides
Number of
runs identified
IQGAP1 6 3/4
14-3-3 gamma 4 2/4
VASP 5 3/4
P21 Arc 3 2/4
LASP-1 4 3/4
kinesin 4 3/4
Dynein heavy chain 5 6 4/4
Valosin-containing protein
(VCP)
15 4/4
Nipsnap 2 2/4
doi:10.1371/journal.pone.0023813.t001
Table 2. List of identified proteins from untreated and CXCL8 stimulated cells in LC/MS/MS analysis.
Untreated CXCL8 treated Both Untreated and CXCL8 treated
Actin cytoskeleton P21-Arc
Gelsolin
Plastin
Vasodilator-stimulated
phosphoprotein (VASP)
Talin 1
Arp 2/3 subunit 2
Lasp-1
Intracellular trafficking Rab7
Annexin 1
Kinesin light chain-2
Valosin-containing protein (VCP)
Secretory carrier membrane
protein 2 (SCAMP2)
Nipsnap homolog 1
Dynein heavy chain 5
Clathrin heavy chain 1
Signaling scaffolding 14-3-3 gamma Similar to LIN-41 YWHAZ (14-3-3 zeta)
IQ motif-containing GTPase
activating protein 1 (IQGAP)
Other Hsp 90
Hsp 75
Chaperonin TCP1
PSMA2 (proteosome subunit)
26S proteosome subunit 9
doi:10.1371/journal.pone.0023813.t002
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PLoS ONE | www.plosone.org 5 August 2011 | Volume 6 | Issue 8 | e23813Figure 2. IQGAP1 is a novel CXCR2 interacting protein. (A) IQGAP1 co-immunoprecipitates with CXCR2. Lysates from differentiated HL-60 cells
expressing CXCR2 stimulated with vehicle (Mock, Untreated) or cells stimulated with 100 ng/ml CXCL8 for 1 min or 5 min were incubated with either
normal rabbit IgG- (Mock IgG) or rabbit anti-CXCR2 antibody-coupled sepharose. Beads were washed and immunoprecipitated proteins were eluted
with Laemmli sample buffer. Samples were analyzed by SDS-PAGE and western blot (IB) for CXCR2 and IQGAP1. (B) CXCR2 co-immunoprecipitates
with IQGAP1-reverse co-immunoprecipitation. Cell lysates were prepared as described above and incubated with either normal rabbit IgG (Mock IgG)
or polyclonal rabbit anti-IQGAP1 antibody. Immunoprecipitated proteins were analyzed by SDS-PAGE and western blot for IQGAP1 and CXCR2. (C &
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also affects the ability of other receptors to effectively use IQGAP1
to mediate chemotaxis.
After extensive experimentation, we are unable to offer proof
that the 1-160 fragment inhibits chemotaxis by directly blocking
the binding of full length IQGAP1 to CXCR2 or the EGFR. In
co-immunoprecipitation experiments, overexpression of IQGAP1
1-160 fragment in HEK-293 cellls or inclusion of the 1-160
fragment in the dHL60 lysate will not block the co-immunopre-
cipitation of CXCR2 with full length IQGAP1 (Supplemental data
Figures S1 and S2). We postulated that if the 1-160 fragment could
bind to full length IQGAP1, then there might be a conformational
change in IQGAP1 that would prevent its binding to Cdc42.
However, we observed that the 1-160 fragment does not block the
association of IQAGAP with Cdc42 (Supplemental Data Figure
S3). In retrospect, this is likely because the region of self-
association for IQGAP1 requires amino acids 763–863 and not the
N terminal domain. From our data it appears that though the 1-
160 fragment of IQGAP1 binds CXCR2, and expression of 1-160
interrupts chemotaxis, IQGAP1 will continue to co-immunopre-
cipitate with CXCR2. This is likely due to the ability of IQGAP1
to bind other adaptor proteins that associate with CXCR2. There
Figure 3. CXCR2 interacts with the amino-terminus of IQGAP1 specifically through amino acids 1–160. (A) Domains contained in the
GST-IQGAP1 fusion construct. Western blot analysis with anti-CXCR2 antibody of differentiated HL-60 CXCR2 lysates (Input) and eluates from (B) GST,
GST-IQGAP1-N-terminus (NT), and IQGAP1-C-terminus (CT) pull-down reactions and (C) GST, GST-IQGAP1-1-265, and -1-160. Data shown are
representative of three separate experiments.
doi:10.1371/journal.pone.0023813.g003
D) Co-localization of CXCR2 and IQGAP1. Immunofluorescence confocal images of CXCR2 and IQGAP1 staining in differentiated HL60 cells stably
expressing CXCR2 and stimulated with vehicle (0 min) or 100 ng/ml of CXCL8 for 1 min, 5 min, and 30 min. Cells were stained with rabbit polyclonal
anti-CXCR2 and mouse monoclonal anti-IQGAP1 antibodies, and incubated with species specific Cy2- and Cy3-conjugated secondary antibodies. Co-
localization is seen at each time point. Overlay images are pseudo-colored where green is IQGAP1 and red is CXCR2. Image represents a single Z-
section of 0.28 mm. Insets are enlarged 2X from original images. (E) Co-localization of IQGAP1 and CXCR2 in human neutrophils. Purified human
neutrophils were induced to polarize in a Zigmond chamber under a gradient of CXCL8 (the arrows indicate the direction of gradient) for 20 min at
37uC. Panels a-c show three representative confocal immunofluorescence images of cells where cells are stained with antibodies against IQGAP1 (red)
and CXCR2 (green). Panel d shows images of cells stained with normal IgG (isotype control). Scale bar =10 mm. Quantitation of percent co-
localization of IQGAP1 and CXCR2 was plotted in panel F.
doi:10.1371/journal.pone.0023813.g002
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might function to block CXCL8 and EGF mediated chemotaxis
which we address below in the discussion.
Discussion
We have developed a highly effective approach to identify novel
dynamic chemokine receptor-interacting proteins. This approach
allows protein complexes to be isolated from cells following various
periods of ligand stimulation and has the potential to temporally
define the components of chemokine receptor-associating complex-
es within the cell. This has important implications for the current
understandingofthe chemotacticresponse.InadditiontoIQGAP1,
the following proteins were found: 14-3-3 gamma, p21-Arc, a
subunit of an Arp 2/3 protein complex, which also localizes to sites
of actin polymerization [19], vasodilator stimulated phosphoprotein
(VASP), LIM and SH3 domain protein 1 (LASP-1), microtubule
motor proteins such as dynein, valosin-containing proteins, Rab39
and Nipsnap (Table 1). We have previously characterized the
association of CXCR2 with VASP and LASP-1 20], both of which
are important in cytoskeletal organization and cell motility. The
Ena/VASP family of proteins can enhance actin polymerization by
recruiting profilin-actin complexes to sites of acting remodeling,
such as the lamellipodia in migrating cells [21,22], while Lasp-1 is a
component of focal adhesions that has recently been shown to play
an important role in cell migration and cell survival [23,24,25].
Each of these actin regulating proteins may provide a link between
the activated chemokine receptor and the acting cytoskeleton.
Twocomponentsofmicrotubulemotorproteinswerealsoamong
the proteins identified with this approach. These proteins may play
a role in the intracellular trafficking of chemokine receptors, as well
as in signaling by transporting signaling proteins to appropriate
cellular locations. For example, kinesins are microtubule motor
proteins that are involved in transporting vesicles and organelles
along microtubules. Interestingly, it was found that 14-3-3 interacts
with kinesin light chain-2 in a phosphorylation-dependent manner
[26]. Dynein heavy chain, another microtubule motor protein, was
also identified in complexes from stimulated cells. Furthermore,
microtubules are known to play a role in the endocytosis of other G
protein-coupled receptors such as beta2-adrenoceptor [27] and m3-
muscarinic receptors [28]. Additional proteins that may play a role
in the intracellular sorting of internalized CXCR2 were among the
novel CXCR2-interacting proteins. Valosin-containing protein is a
molecular chaperone that is involved in the ubiquitin-proteosome
Figure 4. Purified IQGAP1/N-terminus binds directly to GST
CXCR2/C-terminus. Western blot analysis of purified IQGAP1/N-
terminus (NT) and purified protein bound to glutathione Sepharose
beads with GST alone or GST-CXCR2/C-terminus (CT). Briefly, fusion
protein-bound glutathione beads were blocked with 1% BSA for 1 h at
room temp and incubated for 1 h at 4uC with 10 mg purified IQGAP1/N-
terminus in binding buffer. Beads were washed 3X with binding buffer
and bound protein eluted and analyzed by SDS-PAGE and western blot
(IB) for IQGAP1. Data shown are representative of three separate
experiments.
doi:10.1371/journal.pone.0023813.g004
Figure 5. Interaction of IQGAP1 with Cdc42 is enhanced by
CXCL8 stimulation. Lysates from cells stimulated with vehicle (Mock,
Untreated) or cells stimulated with 100 ng/ml CXCL8 for 1 minute or 5
minute were incubated with either normal rabbit IgG- (Mock IgG) or
rabbit anti-IQGAP1 antibody and Protein A/G agarose beads. Immuno-
precipitated proteins were eluted with Laemmli sample buffer (A)
Representative western blot of samples analyzed by SDS-PAGE and
immunoblotted (IB) for IQGAP1 and Cdc42 (B) Quantitation using
densitometry of fold increase in amount of Cdc42 that co-immunopre-
cipitated with IQGAP1 following CXCL8 stimulation over amount of
Cdc42 that co-immunoprecipitates from lysates of untreated cells.
Graph represents mean fold increase 6 s.e.m. from three separate
experiments. There is a statistically significant increase in the amount of
Cdc42 that co-immunoprecipitates with IQGAP1 following 1 minute of
CXCL8 stimulation as represented by the asterisk (p-value ,0.05, Mann
Whitney U-test).
doi:10.1371/journal.pone.0023813.g005
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that canfacilitate endocytosis[31]. Nipsnaps area familyof proteins
that have a potential role in vesicular trafficking because of their
homology to synaptosomal-associated proteins (SNAP) [32]. In
addition, NIPSNAP4 was shown to interact with the Salmonella
enterica factor SpiC, which inhibits lysosomal maturation [33].
Among the proteins identified in the untreated samples was 14-
3-3 gamma. 14-3-3 gamma is a signaling adaptor molecule that
can bind regulators of G-protein signaling (RGS) proteins and
inhibit their activity [34,35]. RGS proteins are GTPase activating
proteins (GAPs) that specifically activate the Ga subunit [36,37]. It
has been previously shown that RGS12 interacts with CXCR2
through its PDZ (PSD95/DlgA/ZO-1) domain [38]. Therefore,
the interaction of CXCR2 with 14-3-3 gamma represents a
potential novel link to signaling pathways through its function as
an adaptor molecule that is a known regulator of RGS proteins.
IQGAP1 binds to CXCR2 in the absence of CXCL8
stimulation and after prolonged ligand stimulation this interaction
is reduced. It is likely that once CXCR2 internalizes, IQGAP1
dissociates from the receptor. CXCL8 stimulation induces
CXCR2 phosphorylation, Cdc42 activation and polarization,
and a rise in intracellular Ca
2+ levels [10] [39] [40]. Activated
Cdc42 and Ca
2+/calmodulin both modulate IQGAP1 activities
and binding partners (reviewed in [1,6]. It has been previously
Figure 6. Boyden chamber assay assessing chemotaxis of HEK293-CXCR2 cells stably expressing empty vector or IQGAP1 1–160.
HEK293-CXCR2 cells, with IQGAP1 1-160 and without (vector only) were stimulated with CXCL8 (A) or EGF (B) and assayed using a Boyden chamber to
determine chemotaxis. A statistically significant difference between cells expressing vector and IQGAP1 1-160 was found and is represented by the
asterisk (p-value , 0.001 (A) and =0.0111 (B); ANOVA). Graph represents the average cell number per 20X field 6 s.e.m. and is representative of three
separate experiments.
doi:10.1371/journal.pone.0023813.g006
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2+/calmodulin by the cell-
permeable inhibitor CGS 9343B impairs the Ca
2+-dependent
interaction of E-cadherin with IQGAP1 [41]. Therefore, we are
interested in whether CXCR2 phosphorylation, Cdc42 activity,
and Ca
2+/calmodulin influence CXCR2/IQGAP1 binding. In
the future, it will be of interest to express dominant negative and
activated Cdc42 mutants and determine whether the interac-
tion between CXCR2 and IQGAP1 is enhanced or disrupted.
Additionally, investigation into the effects of inhibition of CXCR2
phosphorylation using phosphorylation-deficient receptor mutants
and inhibition of Ca
2+/calmodulin through use of a cell-
permeable calcium chelator on the CXCR2/IQGAP1 interaction
will be of interest.
It is of interest that CXCR2 interacts with IQGAP1 between
amino acids 44 and 160 because this region also contains the WW
domain where calmodulin binds. This region of IQGAP1 is
necessary and sufficient for its high affinity interaction with F-Actin
[42]. Studies utilizing point mutations in the WW domain
demonstrated that the IQGAP1 interaction with F-Actin is essential
for its role in the promotion of cell motility [43]. In addition,
interaction of IQGAP1 with calmodulin has been shown to inhibit
the binding of IQGAP1 to actin [44]. Therefore, it is possible that
CXCR2 competes with actin for binding to the WW domain of
IQGAP1, similar to the phenomenon seen with calmodulin.
We describe a novel and effective technique to identify
components of dynamic chemokine receptor protein complexes
within the cell. A number of interesting proteins have been
identified that potentially regulate chemokine receptor function.
These proteins range in function from intracellular trafficking to
cytoskeletal modification. One of the CXCR2 interacting proteins
identified is IQGAP1. We have identified amino acids 1–160 of
IQGAP1 as the CXCR2 interaction domain. This domain can be
utilized to antagonize the CXCR2 mediated chemotaxis. However,
after extensive experimentation, we have concluded that though the
1–160 fragment may inhibit CXCL8 and EGF mediated
chemotaxis, we are still able to co-immunoprecipitate IQGAP1
with CXCR2 in the presence of the 1–160 fragment. Several
scenarios may be considered for the mechanism of action of the 1–
160 fragment, of which scenario 3 appears most promising.
1) CXCR2 might bind the 1–160 fragment and the 1–160
fragment would also bind a full length IQGAP1 monomer,
and in this conformation the IQGAP1 would be unable to
dissociate and bind actin when ligand stimulates the binding
of activated Cdc42 to IQGAP1. In this scenario, the
receptor continues to co-immunoprecipitate with full length
IQGAP1, even though the full length IQGAP1 may no
longer bind receptor. In this case when the 1–160 fragment
binds IQGAP1, it works as a dominate negative for
IQGAP1 function such that IQGAP1 is no longer able to
become fully activated to dissociate and bind and bundle
actin. However, Fukata et al have shown that a 1–216 GST
fragment of IQGAP1 will not pull down endogenous
IQGAP1 [45]. Also Ren et al demonstrated that the self-
association region for IQGAP1 requires amino acids 763–
863[46]. Thus it is doubtful that the 1–160 fragment is
binding full length IQGAP1.
2) The inhibitory effect of the 1–160 fragment might result
from binding of the WW domain in the 1–160 fragment to
F-actin, thus blocking the binding of F-actin to full length
IQGAP1. However, Mateer et al have shown that a 1–210
fragment of IQGAP1 binds F-actin in a mole to mole ratio
and the 1–210 fragment of IQGAP1 co-localizes with the
cortical actin, but not with the actin in stress fibers[42].
Thus, if present in sufficient levels, the 1–160 fragment of
IQGAP1, by binding to F-actin, might block the formation
of IQGAP1 dependent ligand stimulated stress fiber
formation involved in cell motility. This scenario is less
likely if the relative abundance of F-actin is much greater
than the abundance of IQGAP1 or the 1–160 fragment.
3) The 1–160 fragment of IQGAP1 might bind CXCR2,
displacing direct binding of full length IQGAP1 and
blocking the downstream signaling needed for chemotaxis.
However, in this scenario full length IQGAP1 would
continue to co-immunoprecipitate with CXCR2 based upon
the ability of IQGAP1 to bind other proteins that associate
with adaptor proteins that bind CXCR2. However, in this
scenario, the ‘‘tag along’’ binding would not allow functional
activation of ligand mediated signaling through CXCR2/
IQGAP1 interaction.
4) The 1–160 fragment might inhibit CXCR2 and EGFR
mediated chemotaxis by binding to WASP are replacing the
ability of IQGAP1 to bind WASP, thus preventing its ability
to generate branched actin filaments needed for chemotaxis.
WASP normally binds the WW domain of IQGAP1
through its EVH1 domain then WASP binds Arp2/3
through its verprolin-connecting-acidic domain and CDC42
through its gap related domain [47]. CDC42 also binds
IQGAP1 in its gap related domain. Since the 1–160
fragment of IQGAP1 would directly bind to WASP
[47,48], this would prevent the binding of WASP to full
length IQGAP1 and block receptor mediated signaling.
Thus while CXCR2 might still bind full length IQGAP1,
upon ligand induced dissociation from the receptor, the full
length IQGAP1 would not be able to bind WASP to
mediate Arp2/3/Cdc42 promoted branched actin filament
polymerization, since the WASP would remain pre-bound
to the 1–160 fragment. Of note, the 1–160 fragment did not
reduce the association of IQGAP1 with Cdc42 through its
GRD domain, but this doesn’t rule out the possibility that
there would be an impairment of branched actin filament
polymerization in response to chemokine in the presence of
the 1–160 fragment(Supplemental data Figure S3).
We postulate that under normal circumstances, when IQGAP1
is bound to CXCR2, IQGAP1 is unable to bind actin and when
ligand stimulates CXCR2 mediated events, including activation
of Cdc42, the IQGAP1 binds activated Cdc42, enabling
IQGAP1 to undergo a conformational change such that it is
released from the receptor so that it can dimerize and bind F-
actin through the WW domains, cross-link actin filaments, and
mediate chemotaxis. This concept is further supported by studies
utilizing point mutations in the WW domain (within 44 and 160
of IQGAP1) result in a loss of IQGAP1 mediated cell motility
[42]. Moreover, IQGAP1 binding of calmodulin places IQGAP1
in a conformation that not only inhibits the binding of IQGAP1
to actin but also inhibits its ability to bind to other partners
needed for chemotaxis [42].
In agreement with our work shown here, Yamaoka-Tojo et al.,
showed that VEGF binding to VEGFR2 stimulates the directbinding
of IQGAP1 to the cytoplasmic domain of the VEGFR2 (aa 790-958)
and association of Rac1 with IQGAP1[49], much like activation of
the carboxyl-terminal domain of CXCR2 stimulates the binding of
activated Cdc42 to IQGAP1 to stimulate CXCR2 mediated
chemotaxis. siRNA to IQGAP1 inhibits VEGF mediated cell
motility. Moreover, Bensenor et al, demonstrated that FGF2 binding
to FGFR1 stimulates IQGAP1-dependent lamellipodial protrusion
and cell migration [48]. This event was coordinated by Arp2/3 and
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that IQGAP1 binds to the cytoplasmic tail of FGFR1 and to N-
WASP to stimulate the nucleation of branched actin filaments. We
show here that the EGFR mediated effects on chemotaxis are also
disrupted when the competing peptide fragment of IQGAP1 1-160 is
expressed in cells. We also show for the first time the direct binding of
IQGAP1 to the G protein-coupled receptor, CXCR2, and we show
that knock-downof IQGAP1 inhibits CXCR2 mediated chemotaxis.
Moreover, we clearly define for the first time the region of IQGAP1
that is involved in receptor binding to mediate chemotaxis and
demonstrate that CXCR2 activation increases the association of
Cdc42 to IQGAP1.
Finally, our characterization herein of CXCR2 interactions
with several other proteins in the chemosynapse will greatly impact
our current understanding of how the chemotactic response is
relayed from activated chemokine receptors to the cytoskeleton
and intracellular signaling cascades.
Supporting Information
Figure S1 No inhibition of IQGAP1-CXCR2 association
when IQGAP1 1-160 fragment expressing in HEK-293
CXCR2 cells. HEK293-CXCR2 cells were transiently transfected
with either vectorcontrol or IQGAP1 1-160 expression construct.Cells
were stimulated with either CXCL8 (100 ng/ml) or carrier buffer for 5
min at 37uC and co-immunoprecipitation was performed with anti-
CXCR2 antibody conjugated to sepharose beads and immunoblotted
with anti-IQGAP1 or CXCR2 antibody. Experiments were performed
three times with similar results.
(TIF)
Figure S2 No inhibition of IQGAP1-CXCR2 association in
the presence of large amount of IQGAP1 1-160 fragment
added in vitro in dHL-60 cells. Differentiated HL-60 cells were
lysed in lysis buffer (0.1% triton X-100 in PBS). Co-immunoprecip-
itation with anti-CXCR2 antibody was performed in the presence of a
l a r g ea m o u n to fI Q G A P 1f r a g m e n t1 - 1 6 0a m i n oa c i d s( 2 0o r4 0m g )o r
the non-competitive control fragment IQGAP1 161-431 or buffer
only. IQGAP1 and CXCR2 were detected by immunoblot with anti-
IQGAP1 or CXCR2, respectively. Experiments were repeated at least
three times with similar results.
(TIF)
Figure S3 No inhibition of IQGAP1-Cdc42 association
when IQGAP1 1-160 fragment expressing in HEK-293
CXCR2 cells. HEK293-CXCR2 cells were transiently trans-
fected with either vector control or IQGAP1 1-160 expression
construct. Cells were stimulated with either CXCL8 (100 ng/ml)
or carrier buffer for 5 min at 37uC and co-immunoprecipitation
was performed with anti-IQGAP1 polyclonal rabbit antibody
(Santa Cruz, CA) and protein A/G agarose beads. Western blots
were performed with anti-IQGAP1 or Cdc42 antibody, respec-
tively. Experiments were repeated twice with similar results.
(TIF)
Figure S4 Only N-terminal of IQGAP1 1-160 fragment
associates with CXCR2. The lysates of differentiated HL-60
cells were incubated with GST alone or various GST tagged
fragments of IQGAP1. The GST pull-down products were resolved
in a SDS-PAGE and detected by Western blot with anti-CXCR2
antibody (Santa Cruz Biotech, CA). Cell lysates were loaded as
positive control and a ladder of fragments were observed due to the
different forms of glycosylation of CXCR2 in differentiated HL-60
cells. CXCR2 was pulled down only with the GST tagged N-
terminal and the GST-1-265 amino acid fragment of IQGAP1.
(TIF)
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